Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bakuchiol vs Retinol for facial photoaging
NCT03112863Phase 1Completed
- Sponsor
- University of California, Davis
- Start
- Mar 2017
- Primary completion
- Mar 2019
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, triple-blind trial of bakuchiol in rhytides and photoaging (2 arms), sponsored by University of California, Davis. Primary endpoints: Change in Wrinkle Appearance at 12 weeks and Percentage of Participants With Change in Appearance of Skin Pigmentation at 12 weeks. Started Mar 2017; status: completed.
02
Drugs
bakuchiol
03
Conditions
rhytidesphotoaging
Beyond the preview
Go deeper on NCT03112863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03112863.